We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 378.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMIDH
RNS Number : 2550Z
Immunodiagnostic Systems Hldgs PLC
13 March 2017
Immunodiagnostic Systems Holdings plc.
13 March 2017
Further re CEO Appointment
Immunodiagnostic Systems Holdings plc ("IDS" or the "Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market confirms that incoming CEO, Regis Duval, is the beneficial owner of 29,397 ordinary shares of 2p each in the Company. This disclosure is made in accordance with AIM Rule 17. Regis Duval acquired these shares prior to joining IDS.
For further information:
Immunodiagnostic Systems Holdings plc Tel: +44 (0) 191 519 0660
Paul Martin, Group Finance Director
Peel Hunt LLP Tel: +44 (0) 20 7418 8900
James Steel
Oliver Jackson
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAGGURPWUPMURW
(END) Dow Jones Newswires
March 13, 2017 04:31 ET (08:31 GMT)
1 Year Immunodiagnostic Systems Chart |
1 Month Immunodiagnostic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
